High Court considers requirements for an exclusive patent licence (Neurim v Mylan)

In the LexisNexis case analysis, Senior IP Associate, Will Smith, talks about the decision in the following matter: Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN) [2020] EWHC 3270 (Pat). This case concerned the licensing of patented technology, specifically the use of licence terms relating to the control of proceedings. 

Click here to read more >

Full article available on PatentHub

Latest insights

More Insights
featured image

Be quick to file an application for a cost decision at the UPC - or it could be a costly mistake

6 minutes Aug 21 2025

Read More
featured image

Reshaping the Game: An EU-Focused Legal Guide to Generative and Agentic AI in Gaming

Aug 14 2025

Read More
Curiosity line green background

Hong Kong’s Clinics to Prepare for Licensing Regime

Aug 13 2025

Read More